Prestige Consumer Healthcare (PBH) EPS (Basic) Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) EPS (Basic) Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.68 Bn | 40.02 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 32.31 Bn | 30.63 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.87 Bn | 17.98 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.97 Bn | 11.44 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.75% |
| Sep 30, 2025 | -21.38% |
| Jun 30, 2025 | -2.46% |
| Mar 31, 2025 | 1.48% |
| Dec 31, 2024 | 15.39% |
| Sep 30, 2024 | 1.60% |
| Jun 30, 2024 | -8.12% |
| Mar 31, 2024 | 120.61% |
| Dec 31, 2023 | 2.01% |
| Sep 30, 2023 | 5.22% |
| Jun 30, 2023 | -2.65% |
| Mar 31, 2023 | -565.26% |
| Dec 31, 2022 | 4.73% |
| Sep 30, 2022 | 13.54% |
| Jun 30, 2022 | -4.54% |
| Mar 31, 2022 | 46.52% |
| Dec 31, 2021 | 22.63% |
| Sep 30, 2021 | 1.85% |
| Jun 30, 2021 | 32.47% |
| Mar 31, 2021 | -3.16% |